GlassScriptPhysician profile
Yue Jiang
NPI 1255886446
$721.51
in general payments reported to CMS, 2019-2025
8 companies · $118 in 2025
The $118 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.52 · 2021: $14.98 · 2022: $97.78 · 2023: $206 · 2024: $186 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.23 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $379.38 | 2022-2025 | |
| Straumann USA LLC | $75.00 | 2023 | |
| Pacira Therapeutics, INC. | $73.28 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $62.91 | 2021-2024 | Arestin |
| Align Technology, INC. | $50.19 | 2019-2025 | Invisalign |
| Janssen Biotech, INC. | $34.21 | 2024 | Erleada, Akeega, Balversa |
| Philips North America LLC | $31.00 | 2019-2024 | (E55) Oral Health Care Und |
| Solventum Corporation | $15.54 | 2024 | 3m Filtek, 3m Relyx, 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yue Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.